期刊
MULTIPLE SCLEROSIS JOURNAL
卷 20, 期 12, 页码 1654-1657出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458514521517
关键词
Diagnosis; disease progression; multiple sclerosis; relapsing remitting multiple sclerosis; secondary progressive multiple sclerosis; transition
资金
- National Multiple Sclerosis Society
Secondary progressive multiple sclerosis (MS) is typically defined as deterioration independent of relapses for >= 6 months following an initial relapsing-remitting course; however, this definition is not always easily applied in clinical practice and the declaration of the change in clinical phenotype is often delayed. To identify the length of time required to re-classify relapsing-remitting MS (RRMS) patients whom have clinically transitioned to secondary progressive MS (SPMS) in clinical practice. We reviewed 123 patients with long-term follow-up and identified a sub-group whom transitioned from RRMS to SPMS, then characterized this transition period. There were 14/20 patients who transitioned during the follow-up period that had visits with uncertainty related to the clinical phenotype characterized by possible, but not definitive progression. The mean duration of this period of uncertainty was 2.9 +/- 0.8 years. A period of diagnostic uncertainty regarding the transition from RRMS to SPMS existed in many of our patients. Potential reasons included the subtle nature of early progressive disease and caution in applying a progressive label, in light of the lack of evidence-based treatments as well as third-party payer concerns. Delay in definitive identification of an SPMS phenotype has a variety of implications related to patient care and research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据